Journals / Epilepsi / 2016 / Cilt: 22 - Sayı: 3

Sudden Unexpected Death in Epilepsy: Two Case Reports

Epilepside Ani Beklenmedik Ölüm (SUDEP): İki Olgu Sunumu

Journal
Epilepsi
Pages
123–128
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These 2 cases of probable SUDEP may contribute to increased awareness of SUDEP and its features among neurologists.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Sudden Unexpected Death in Epilepsy (SUDEP) is generally defined as sudden, unexpected, witnessed or unwitnessed, non-traumatic, and non-drowning death in patients with epilepsy, excluding documented status epilepticus.
📊
Key Findings & Data:Case 1: A 33-year-old female patient with generalized tonic-clonic seizures for nearly 20 years was referred to the clinic because of lack of complete seizure control despite years of different antiepileptic drug combinations.
💡
Conclusion & Impact:These 2 cases of probable SUDEP may contribute to increased awareness of SUDEP and its features among neurologists.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Abstract

Sudden Unexpected Death in Epilepsy (SUDEP) is generally defined as sudden, unexpected, witnessed or unwitnessed, non-traumatic, and non-drowning death in patients with epilepsy, excluding documented status epilepticus. Reported SUDEP cases in Turkey are limited. Two cases of patients who died with diagnosis of probable SUDEP are described in the present report. Case 1: A 33-year-old female patient with generalized tonic-clonic seizures for nearly 20 years was referred to the clinic because of lack of complete seizure control despite years of different antiepileptic drug combinations. While in treatment, patient had a healthy pregnancy and seizure control was achieved with lamotrigine. Upon recurrence of seizures after pregnancy, valproate 300 mg/day was added to lamotrigine 150 mg/day. Patient died with diagnosis of probable SUDEP 2 years after the birth of the child. Case 2: A 42-year-old female patient with intractable complex partial and secondary generalized tonic-clonic seizures for about 30 years was admitted to the clinic. She had a history of epilepsy surgery. Topiramate therapy was added to carbamazepine 1200 mg/day and levetiracetam 2000 mg/day treatment. Subsequently, posterior temporal resection was performed, vagal nerve stimulation (VNS) was applied and barbexaclone 25 mg/day was added. Five months after the application of VNS, the patient died with diagnosis of probable SUDEP. These 2 cases of probable SUDEP may contribute to increased awareness of SUDEP and its features among neurologists.

Özet

‘Epilepside Ani Beklenmedik Ölüm’ (Sudden Unexpected Death in Epilepsy - SUDEP), epilepsi hastalarında ani, beklenmedik, tanıklı veya tanık olmadan, travma ve suda boğulma ile ilişkili olmayan, belgelenmiş status epileptikusa bağlı olmayan ölüm olarak tanımlanmaktadır. Ülkemizde bildirilen SUDEP olguları sınırlı sayıdadır. Biz muhtemel SUDEP tanısı ile kaybettiğimiz iki olgu sunuyoruz. Olgu 1: Yaklaşık 20 yıldır jeneralize tonik-klonik (JTK) nöbetleri olan 33 yaşındaki kadın hasta, farklı zamanlarda ve kombinasyonlarla kullandığı antiepileptik ilaçlara rağmen tam nöbet kontrolü sağlanamaması nedeniyle tarafımıza başvurdu. Takiplerinde lamotrijin tedavisi altında sağlıklı bir gebelik geçirdi ve nöbet kontrolü sağlandı. Doğumdan sonra nöbetinin nüksetmesi üzerine lamotrijin 150 mg/gün tedavisine valproat 300 mg/gün eklenen hasta doğumdan iki yıl sonra muhtemel SUDEP tanısı ile kaybedildi. Olgu 2: Yaklaşık 30 yıldır kompleks parsiyel nöbet (KPN) ve sekonder JTK şeklinde tedaviye dirençli nöbetleri olan ve epilepsi cerrahisi uygulanan 42 yaşındaki kadın hasta tarafımıza başvurdu. Mevcut karbamazepin 1200 mg/gün, levetirasetam 2000 mg/gün tedavilerine topiramat eklendi, ardından sırasıyla posterior temporal rezeksiyon, vagal sinir uyarımı (VNS) uygulandı ve barbeksaklon 25 mg/gün eklendi. Hasta VNS uygulanmasından beş ay sonra muhtemel SUDEP tanısı ile kaybedildi. Biz muhtemel SUDEP olan bu iki olgumuzu bildirerek nörologların SUDEP konusundaki farkındalığını artırmayı ve ülkemize ait SUDEP olgularının özelliklerinin ortaya konmasına katkıda bulunmayı hedefledik.

🔖

Cite This Article

GENÇ, G., KOÇ, G., BEK, S., GÖKÇİL, Z. (2016). Sudden Unexpected Death in Epilepsy: Two Case Reports. Epilepsi, Cilt: 22 - Sayı: 3, 123–128. https://ajindex.com/articles/159950

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Nashef L. Sudden unexpected death in epilepsy: terminology and definitions. Epilepsia 1997;38:6–8. Annegers JF. United States perspective on definitions and classifications. Epilepsia 1997;38(11 Suppl):9–12.
  2. Nashef L, So EL, Ryvlin P, Tomson T. Unifying the definitions of sudden unexpected death in epilepsy. Epilepsia 2012;53(2):227–33.
  3. Leestma JE, Annegers JF, Brodie MJ, Brown S, Schraeder P, Siscovick D, et al. Sudden unexplained death in epilepsy: observations from a large clinical development program. Epilepsia 1997;38(1):47–55. Gürses C. SUDEP-Sudden Unexpected Death in Epilepsy. Turkiye Klinikleri J Neurol-Special Topics 2012;5(1):52–5.
  4. Tomson T, Sveinsson O. Sudden Unexpected Death in Epilepsy (SUDEP): An Overview. Epilepsi 2013;19(3):91–6.
  5. Ficker DM, So EL, Shen WK, Annegers JF, O’Brien PC, Cascino GD, et al. Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology 1998;51(5):1270–4.
  6. Glasscock E, Yoo JW, Chen TT, Klassen TL, Noebels JL. Kv1.1 potassium channel deficiency reveals brain-driven cardiac dysfunction as a candidate mechanism for sudden unexplained death in epilepsy. J Neurosci 2010;30(15):5167–75.
  7. Nayak C, Sinha S, Nagappa M, Thennarasu K, Taly AB. Lack of heart rate variability during apnea in patients with juvenile myoclonic epilepsy (JME).Sleep Breath 2015;19(4):1175–83.
  8. Assenza G, Mecarelli O, Tombini M, Pulitano P, Pellegrino G, Benvenga A, et al. Hyperventilation induces sympathetic overactivation in mesial temporal epilepsy. Epilepsy Res 2015;110:221–7.
  9. Seymour N, Granbichler CA, Polkey CE, Nashef L. Mortality after temporal lobe epilepsy surgery. Epilepsia 2012;53(2):267–71.
  10. Granbichler CA, Nashef L, Selway R, Polkey CE. Mortality and SUDEP in epilepsy patients treated with vagus nerve stimulation. Epilepsia 2015;56(2):291–6. Walczak T. Do antiepileptic drugs play a role in sudden unexpected death in epilepsy? Drug Saf 2003;26(10):673–83. Timmings PL. Sudden unexpected death in epilepsy: is carbamazepine implicated? Seizure 1998;7(4):289–91.
  11. Aurlien D, Larsen JP, Gjerstad L, Taubøll E. Increased risk of sudden unexpected death in epilepsy in females using lamotrigine: a nested, case-control study. Epilepsia 2012;53(2):258–66.
  12. Danielsson BR, Lansdell K, Patmore L,Tomson T. Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents. Epilepsy Res 2005;63(1):17–25.
  13. Hesdorffer DC, Tomson T, Benn E, Sander JW, Nilsson L, Langan Y, et al. Combined analysis of ri